PHNPharmanutra S.p.A.
88.70EUR-2.10%Mkt Cap: 849.32M EURP/E: 40.32Last update: 2026-06-01

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internati…

Indicators:|

Key Statistics

Company
Market Cap849.32M EUR
Enterprise Value859.85M EUR
Revenue (TTM)138.73M EUR
Gross Profit102.87M EUR
Net Income (TTM)20.00M EUR
Revenue/Share14.52 EUR
Last Price88.70 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees128
CountryIT
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINIT0005274094
Valuation
P/E (Trailing)40.32
P/E (Forward)29.57
PEG
EV/EBITDA25.98
EV/Revenue6.20
P/S6.25
P/B11.68
EPS (TTM)2.20
EPS (Forward)3.06
52W Range
38.7595% of range91.50
52W High91.50 EUR
52W Low38.75 EUR
Profitability
Gross Margin77.38%
Oper. Margin15.76%
EBITDA Margin23.85%
Profit Margin15.05%
ROE28.03%
ROA15.97%
Growth
Revenue Growth24.50%
Earnings Growth44.00%
Cash Flow & Leverage
Operating CF19.56M EUR
CapEx (TTM)3.13M EUR
FCF Margin10.49%
FCF Yield1.71%
Net Debt-9.91M EUR
Net Debt/EBITDA-0.30
Balance Sheet
Debt/Equity0.29
Current Ratio2.38
Quick Ratio2.11
Book Value/Sh7.758 EUR
Cash/Share3.021 EUR
Dividends
Fwd Div Rate1.200 EUR
Trail. Div Rate0.0000 EUR
Div. Yield1.34%
5Y Avg Yield1.44%
Payout Ratio45.45%
Ex-Div DateMay 4, 2026
Pay Date
Analyst Consensus
Rating
Target (Mean)81.33 EUR
Target Range76.00 EUR86.00 EUR
# Analysts3
Ownership
Shares Out.9.58M
Float3.28M
Insiders65.02%
Institutions16.65%
Technical
SMA 5080.76 (+9.8%)
SMA 20060.80 (+45.9%)
Beta0.10
S&P 52W Chg27.94%
Avg Vol (30d)12.98K
Avg Vol (10d)9.45K
Technical Indicators
RSI (14)68.0
MACD2.4614
MACD Signal2.3936
MACD Hist.+0.0678
BB Upper94.97 EUR
BB Middle84.86 EUR
BB Lower74.75 EUR
BB Width23.83%
ATR (14)2.870 EUR
Vol Ratio (20d)1.16x